Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

Affiliations

Shubhadeep D. Sinha: Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate
Vamsi Krishna Bandi: Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate
Bala Reddy Bheemareddy: Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate
Pankaj Thakur: Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate
Sreenivasa Chary: Clinical Development and Medical Affairs, Hetero Group, Hetero Corporate
Kalpana Mehta: Department of Nephrology, B.L.Y Nair Hospital
Vikranth Reddy Pinnamareddy: Care Hospitals
Rajendra Pandey: Department of Nephrology, Institute of Post Graduate Medical Education and Research Kolkata
Subhramanyam Sreepada: Sri Raghavendra Hospital
Santosh Durugkar: Ashwini Hospital and Ramakanth Heart Care Center

Abstract

Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.

ISSN: 1471-2369 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
Website: http://bmcnephrol.biomedcentral.com